|
KR20190098945A
|
|
Wet granulation tablets with improved stability and method for preparing the same
|
|
KR20200046290A
|
|
Method for Preparation of Apixaban
|
|
KR20190031660A
|
|
Wet granulation tablets with improved stability and method for preparing the same
|
|
KR20150010142A
|
|
Novel method for manufacturing of N-(5-[4-[4-methyl-piperazino-methyl]benzolamido)-2-methylphenyl-4-[3-pyridyl]-2-pyrimidin-amine
|
|
KR20100114872A
|
|
Methods of manufacturing sustained release solid formulations
|
|
KR20120025678A
|
|
New synthetic method of 9-[2-phosphonomethoxy)ethyl]adenine
|
|
KR20110111782A
|
|
Novel synthetic method of propiverine hydrochloride
|
|
KR20110012608A
|
|
Granisetron orally disintegrating tablets and manufacturing processes thereof
|
|
KR20100010079A
|
|
A novel synthetic method of itopride and derivatives
|
|
KR20090100759A
|
|
Novel synthetic method of intermediate for mosapride
|
|
KR20090088997A
|
|
Sustained release solid formulations and methods of manufacturing the same
|
|
KR20080104910A
|
|
Sustained release solid formulations and methods of manufacturing the same
|
|
KR100844336B1
|
|
New synthetic method of levobupivacaine and its hydrochloride
|
|
KR100803746B1
|
|
New synthetic method of raloxifene
|
|
KR100806731B1
|
|
New synthetic method of 2',6'-pipecoloxylidide
|
|
KR100647068B1
|
|
Process for preparing racemic n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine
|
|
KR20060104761A
|
|
Process for preparing lercanidipine hydrochloride
|
|
KR100522392B1
|
|
Process for preparation of granisetron hydrochloride salt
|
|
KR20050100267A
|
|
Process for preparation of simvastatin
|
|
KR20050001074A
|
|
A prolonged action tablet of felodipine and method of preparation thereof
|
